Literature DB >> 8381809

Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.

R Sinclair1, M M Binns, E D Chirnside, J A Mumford.   

Abstract

The N-terminal fragment comprising residues +1 to +50 (gB1-50) of equine herpesvirus type 1 (EHV-1) glycoprotein B was expressed as a glutathione S-transferase fusion protein in Escherichia coli. Recombinant gB1-50 (rgB1-50) was recognized in immunoblots by sera from rabbits immunized with EHV-1 and by convalescent-phase sera from horses with natural EHV-1 infections. An enzyme-linked immunosorbent assay (ELISA) for monitoring antibody levels against EHV-1 was developed by using rgB1-50, and its specificity was assessed with a panel of reference antisera against other equine viruses. A specific cross-reaction was detected with EHV-4, which was confirmed by inhibition ELISA. Convalescent-phase sera from horses with natural EHV-1 or EHV-4 infections possessed antibody titers against rgB1-50 ranging from 1:2,000 to 1:64,000, indicating the presence of an immunodominant antigenic site. The study demonstrated the potential application of rgB1-50 as a diagnostic antigen and highlights the glutathione S-transferase fusion system as a simple and effective method of producing purified milligram quantities of antigen.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381809      PMCID: PMC262747          DOI: 10.1128/jcm.31.2.265-271.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  46 in total

1.  Cultivation of equine abortion virus in fetal horse tissue in vitro.

Authors:  C C RANDALL; F W RYDEN; E R DOLL; F S SCHELL
Journal:  Am J Pathol       Date:  1953 Jan-Feb       Impact factor: 4.307

2.  Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction.

Authors:  P C Sharma; A A Cullinane; D E Onions; L Nicolson
Journal:  Equine Vet J       Date:  1992-01       Impact factor: 2.888

3.  Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.

Authors:  K Keegan; M S Collett
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

4.  Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D.

Authors:  H J Geerligs; M Feijlbrief; M Bolk; C A Bos; J W Drijfhout; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5.  Comparative studies of the proteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3: antibody response of the natural hosts.

Authors:  B S Crabb; M J Studdert
Journal:  J Gen Virol       Date:  1990-09       Impact factor: 3.891

6.  Pseudorabies virus glycoprotein gI: in vitro and in vivo analysis of immunorelevant epitopes.

Authors:  W Fuchs; H J Rziha; N Lukàcs; I Braunschweiger; N Visser; D Lütticken; C S Schreurs; H J Thiel; T C Mettenleiter
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

7.  Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.

Authors:  P X Guo; S Goebel; M E Perkus; J Taylor; E Norton; G Allen; B Languet; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Transcript analysis of the equine herpesvirus 1 glycoprotein B gene homologue and its expression by a recombinant vaccinia virus.

Authors:  C W Bell; D B Boyle; J M Whalley
Journal:  J Gen Virol       Date:  1990-05       Impact factor: 3.891

9.  Equine herpesvirus type 1: detection of viral DNA sequences in aborted fetuses with the polymerase chain reaction.

Authors:  A Ballagi-Pordány; B Klingeborn; J Flensburg; S Belák
Journal:  Vet Microbiol       Date:  1990-05       Impact factor: 3.293

10.  Development and evaluation of an ELISA using secreted recombinant glycoprotein B for determination of IgG antibody to herpes simplex virus.

Authors:  M G Revello; R Gualandri; R Manservigi; G Gerna
Journal:  J Virol Methods       Date:  1991-09       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.